BioCentury
ARTICLE | Company News

Abbott, AstraZeneca deal

June 15, 2015 7:00 AM UTC

Abbott and AstraZeneca partnered to develop and commercialize companion diagnostics to identify patients with severe asthma most likely to benefit from tralokinumab from AZ’s MedImmune LLC unit. Abbo...